$ENSG
ENSIGN GROUP, INC Stock $ensg

$ensg Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000112537624000064 Filed on May 01, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$1.036B	$1.010B
YoY Change	12.48%	13.91%
Cost Of Revenue	$820.4M	$793.5M
YoY Change	14.33%	13.95%
Gross Profit	$215.9M	$216.7M
YoY Change	5.94%	13.73%
Gross Profit Margin	20.84%	21.45%
Selling, General & Admin	$115.1M	$114.8M
YoY Change	6.25%	11.07%
% of Gross Profit	53.31%	52.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.49M	$19.66M
YoY Change	16.44%	14.87%
% of Gross Profit	9.49%	9.07%
Operating Expenses	$135.6M	$134.5M
YoY Change	7.67%	11.61%
Operating Profit	$85.97M	$82.22M
YoY Change	10.4%	9.81%
Interest Expense	$5.044M	-$1.964M
YoY Change	-349.33%	-196.46%
% of Operating Profit	5.87%	-2.39%
Other Income/Expense, Net	$6.093M	$9.344M
YoY Change	17.13%	166.44%
Pretax Income	$92.06M	$89.60M
YoY Change	13.58%	14.31%
Income Tax	$20.88M	$20.64M
% Of Pretax Income	22.68%	23.03%
Net Earnings	$71.01M	$68.84M
YoY Change	10.96%	15.01%
Net Earnings / Revenue	6.85%	6.81%
Basic Earnings Per Share	$1.26	$1.22
Diluted Earnings Per Share	$1.22	$1.19
COMMON SHARES
Basic Shares Outstanding	56.92M shares	56.67M shares
Diluted Shares Outstanding	58.01M shares	57.92M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$501.5M	$526.3M
YoY Change	13.97%	51.64%
Cash & Equivalents	$477.3M	$511.8M
Short-Term Investments	$24.13M	$14.46M
Other Short-Term Assets	$11.77M	$42.45M
YoY Change	-71.71%	427.28%
Inventory
Prepaid Expenses
Receivables	$547.1M	$519.4M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.115B	$1.088B
YoY Change	20.21%	31.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.178B	$2.923B
YoY Change	-57.64%	191.66%
Goodwill	$77.24M	$77.24M
YoY Change	0.48%	0.48%
Intangibles	$6.703M	$6.559M
YoY Change	6.87%
Long-Term Investments	$112.8M	$107.7M
YoY Change	31.46%	31.22%
Other Assets	$105.1M	$106.2M
YoY Change	39.92%	43.59%
Total Long-Term Assets	$3.322B	$3.220B
YoY Change	9.84%	6.22%
TOTAL ASSETS
Total Short-Term Assets	$1.115B	$1.088B
Total Long-Term Assets	$3.322B	$3.220B
Total Assets	$4.437B	$4.308B
YoY Change	12.27%	11.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$88.65M	$82.64M
YoY Change	13.36%	1.43%
Accrued Expenses	$627.5M	$594.9M
YoY Change	24.76%	25.31%
Deferred Revenue	$7.152M	$8.582M
YoY Change	31.04%	5.4%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.017M	$3.983M
YoY Change	3.45%	3.43%
Total Short-Term Liabilities	$730.8M	$709.7M
YoY Change	18.06%	21.26%
LONG-TERM LIABILITIES
Long-Term Debt	$143.6M	$144.5M
YoY Change	-2.61%	-2.57%
Other Long-Term Liabilities	$18.72M	$1.871B
YoY Change	-98.96%	12942.52%
Total Long-Term Liabilities	$162.3M	$2.015B
YoY Change	-91.64%	1138.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$730.8M	$709.7M
Total Long-Term Liabilities	$162.3M	$2.015B
Total Liabilities	$2.774B	$2.731B
YoY Change	8.18%	7.4%
SHAREHOLDERS EQUITY
Retained Earnings	$1.276B	$1.208B
YoY Change	19.92%	20.45%
Common Stock	$499.5M	$486.4M
YoY Change	13.36%	13.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.657B	$1.578B
YoY Change
Total Liabilities & Shareholders Equity	$4.437B	$4.308B
YoY Change	12.27%	11.55%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$71.01M	$68.84M
YoY Change	10.96%	15.01%
Depreciation, Depletion And Amortization	$20.49M	$19.66M
YoY Change	16.44%	14.87%
Cash From Operating Activities	$76.94M	$35.31M
YoY Change	-35.75%	-26.96%
INVESTING ACTIVITIES
Capital Expenditures	$98.15M	$31.38M
YoY Change	287.0%	17.74%
Acquisitions		$494.0K
YoY Change
Other Investing Activities	-$11.76M	-$3.275M
YoY Change	966.97%	-1017.37%
Cash From Investing Activities	-$109.9M	-$34.66M
YoY Change	315.32%	-3.66%
FINANCING ACTIVITIES
Cash Dividend Paid		$3.396M
YoY Change		6.09%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$975.0K
YoY Change		-3.18%
Cash From Financing Activities	-1.531M	1.556M
YoY Change	469.14%	-192.95%
NET CHANGE
Cash From Operating Activities	76.94M	35.31M
Cash From Investing Activities	-109.9M	-34.66M
Cash From Financing Activities	-1.531M	1.556M
Net Change In Cash	-34.50M	2.213M
YoY Change	-137.1%	-79.32%
FREE CASH FLOW
Cash From Operating Activities	$76.94M	$35.31M
Capital Expenditures	$98.15M	$31.38M
Free Cash Flow	-$21.21M	$3.932M
YoY Change	-122.48%	-81.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42451000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1046930000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1101560000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1090771000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1821024000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1756430000	usd
CY2024Q1	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	107666000	usd
CY2023Q4	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	92687000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	66486000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	67124000	usd
CY2023Q4	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	40205000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6559000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6525000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	77241000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	76869000	usd
CY2024Q1	us-gaap	Assets Assets	4308410000	usd
CY2023Q4	us-gaap	Assets Assets	4177541000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	82635000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	92811000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	294208000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	332568000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	85898000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82526000	usd
CY2024Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	62589000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	60000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	465707000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1208074000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1142653000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3390000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3390000	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	116569000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	116555000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1491865000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	5566000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	5452000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1583467000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1497317000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4308410000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4177541000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35036000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1088188000	usd
CY2024Q1	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	39686000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	54664000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	180408000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	168228000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3983000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3950000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	734747000	usd
CY2024Q1	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	144533000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	60000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	486336000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1577901000	usd
CY2024Q1	us-gaap	Operating Lease Income Comprehensive Income Extensible List OperatingLeaseIncomeComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2023Q1	us-gaap	Operating Lease Income Comprehensive Income Extensible List OperatingLeaseIncomeComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#RevenueFromContractWithCustomerExcludingAssessedTax
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	709721000	usd
CY2023Q4	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	145497000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1701652000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1639326000	usd
CY2024Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	117364000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	111246000	usd
CY2024Q1	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	51673000	usd
CY2023Q4	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	49408000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2724943000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2680224000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60294000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56904000	shares
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1010172000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	886841000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	799263000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	696326000	usd
CY2024Q1	ensg	Rent Cost Of Services RentCostOfServices	51876000	usd
CY2023Q1	ensg	Rent Cost Of Services RentCostOfServices	46637000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	57158000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51891000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19657000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17112000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	927954000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	811966000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	82218000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	74875000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1964000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2036000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9344000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5543000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7380000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3507000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	89598000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78382000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20638000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18413000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	68960000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	59969000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	125000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	117000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	68835000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.22
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56337000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55300000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57921000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57098000	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1497317000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6229000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	6165000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	14000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0600
CY2024Q1	us-gaap	Dividends Dividends	3414000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8231000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	10000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	3000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1583467000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1248800000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2654000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	5068000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	20000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0575
CY2023Q1	us-gaap	Dividends Dividends	3215000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6573000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	77000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	117000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1319754000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	68960000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	59969000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19657000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17112000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	266000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	269000	usd
CY2024Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	195000	usd
CY2023Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	263000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1849000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	638000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	47000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	378000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1887000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8238000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6573000	usd
CY2024Q1	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	199000	usd
CY2023Q1	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	0	usd
CY2024Q1	ensg	Gain Loss On Insurance Claims And Disposal Of Assets GainLossOnInsuranceClaimsAndDisposalOfAssets	171000	usd
CY2023Q1	ensg	Gain Loss On Insurance Claims And Disposal Of Assets GainLossOnInsuranceClaimsAndDisposalOfAssets	-62000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34964000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37136000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-3830000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-4643000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11388000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3444000	usd
CY2024Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	9678000	usd
CY2023Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	10084000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	9059000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	9826000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	606000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6567000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10376000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4278000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-38978000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-28648000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	16173000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13850000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3236000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-813000	usd
CY2024Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	14055000	usd
CY2023Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	9369000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	35312000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48344000	usd
CY2024Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	29437000	usd
CY2023Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	26651000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	494000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	1943000	usd
CY2023Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	0	usd
CY2024Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	486000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	0	usd
CY2024Q1	ensg	Proceeds From Insurance Settlement And Sale Of Productive Assets Investing Activities ProceedsFromInsuranceSettlementAndSaleOfProductiveAssetsInvestingActivities	536000	usd
CY2023Q1	ensg	Proceeds From Insurance Settlement And Sale Of Productive Assets Investing Activities ProceedsFromInsuranceSettlementAndSaleOfProductiveAssetsInvestingActivities	13000	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	12815000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	9767000	usd
CY2024Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	10284000	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	791000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	300000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	357000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34655000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35971000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	975000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1007000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6229000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2654000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	20000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	3396000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	3201000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	278000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	4000	usd
CY2024Q1	ensg	Purchases Of Non Controlling Interest PurchasesOfNonControllingInterest	10000	usd
CY2023Q1	ensg	Purchases Of Non Controlling Interest PurchasesOfNonControllingInterest	77000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	19000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1556000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1674000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2213000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10699000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	509626000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	316270000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	511839000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	326969000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1729000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1769000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	51207000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	46420000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4800000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4900000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3414000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3215000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	80920000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	351100000	usd
CY2024Q1	ensg	Number Of Health Care Facilities NumberOfHealthCareFacilities	302	facility
CY2024Q1	ensg	Number Of Skilled Nursing Beds NumberOfSkilledNursingBeds	31200	bed
CY2024Q1	ensg	Number Of Senior Living Units NumberOfSeniorLivingUnits	3100	senior_living_unit
CY2024Q1	ensg	Number Of Leased Facilities NumberOfLeasedFacilities	218	facility
CY2024Q1	ensg	Number Of Leased Facilities Option To Purchase NumberOfLeasedFacilitiesOptionToPurchase	11	facility
CY2024Q1	ensg	Number Of Leased Facilities NumberOfLeasedFacilities	218	facility
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	114	property
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Interim Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company’s Interim Financial Statements relate to revenue, acquired property and equipment, goodwill, right-of-use assets, impairment of long-lived assets, lease liabilities, general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities and income taxes. Actual results could differ from those estimates.</span></div>
CY2024Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	0	usd
CY2023Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	27264000	usd
CY2023Q1	ensg	Revenue Recognition Family First Coronavirus Response Act Revenue Recognized RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized	26358000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	528902000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	494387000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9463000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9348000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	519439000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	485039000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	68960000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	59969000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	125000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	117000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	68835000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56337000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55300000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.22
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	68960000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	59969000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	125000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	117000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	68835000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56337000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55300000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1584000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1798000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57921000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57098000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1143000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1178000	shares
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	114	property
CY2024Q1	ensg	Number Of Lease Arrangements NumberOfLeaseArrangements	5	lease
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q1	ensg	Skilled Service Facilities SkilledServiceFacilities	264	operation
CY2024Q1	ensg	Skilled Services And Senior Living Campuses SkilledServicesAndSeniorLivingCampuses	27	operation
CY2024Q1	ensg	Senior Living Facilities SeniorLivingFacilities	11	operation
CY2024Q1	ensg	Skilled Services And Senior Living Campuses SkilledServicesAndSeniorLivingCampuses	27	operation
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1010172000	usd
CY2024Q1	ensg	Segment Income Loss SegmentIncomeLoss	91447000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1849000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	89598000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19657000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1964000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	886841000	usd
CY2023Q1	ensg	Segment Income Loss SegmentIncomeLoss	78382000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17112000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2036000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1514678000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1487013000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	413118000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	396242000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1101560000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1090771000	usd
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1849000	usd
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6096000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3971000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2125000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6096000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3873000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2223000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	401000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	404000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	176000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	234000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	234000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	234000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	234000	usd
CY2024Q1	ensg	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	1013000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2125000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4434000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4302000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	76869000	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	372000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	77241000	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	9605000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	12875000	usd
CY2024Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	2661000	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	2883000	usd
CY2024Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	15901000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	15913000	usd
CY2024Q1	us-gaap	Other Restricted Assets OtherRestrictedAssets	5198000	usd
CY2023Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	4870000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	2666000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	2661000	usd
CY2024Q1	us-gaap	Escrow Deposit EscrowDeposit	486000	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	1216000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	12774000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	12662000	usd
CY2024Q1	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	39686000	usd
CY2023Q4	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	40205000	usd
CY2024Q1	ensg	Quality Assurance Fee QualityAssuranceFee	10380000	usd
CY2023Q4	ensg	Quality Assurance Fee QualityAssuranceFee	14035000	usd
CY2024Q1	ensg	Resident Refunds Payable ResidentRefundsPayable	52887000	usd
CY2023Q4	ensg	Resident Refunds Payable ResidentRefundsPayable	51248000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8582000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10834000	usd
CY2024Q1	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	5940000	usd
CY2023Q4	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	6215000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3414000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3396000	usd
CY2024Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	16173000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2024Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	51734000	usd
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	51734000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21693000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17891000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	180408000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	168228000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20638000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18413000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.230
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3983000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3950000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2897000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2941000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	144533000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	145497000	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	6305000	usd
CY2024Q1	ensg	Number Of Option Plans NumberOfOptionPlans	1	plan
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	181000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.043
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.409
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.002
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.041
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.416
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.002
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	181000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	122.69
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	56.23
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	89.84
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	41.60
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3991000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	62.65
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1887000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	39.58
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	181000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	122.69
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	25000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	83.01
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	219000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	28.48
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3928000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	67.19
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1808000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	43.49
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	224818000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	197819000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	146313000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	137048000	usd
CY2024Q1	ensg	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	73361000	usd
CY2023Q4	ensg	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	56759000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	19959000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10950000	usd
CY2024Q1	ensg	Share Based Compensation Arrangement By Share Based Payment Award Restricted Awards Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice	0
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1651949000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2775268000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	987718000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1787550000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	85898000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8231000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6573000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	5770000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	4832000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	58102000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	51891000	usd
CY2024Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	195000	usd
CY2023Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	263000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	147657000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	196805000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	196598000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	196009000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	194981000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	191269000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1701652000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y1M6D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	16589000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	21569000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	21269000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	21176000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	21151000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	21109000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	108459000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	231322000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	51478000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	49201000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	2394000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	1239000	usd
CY2024Q1	ensg	Investment Expense Income InvestmentExpenseIncome	2488000	usd
CY2023Q1	ensg	Investment Expense Income InvestmentExpenseIncome	1280000	usd
CY2024Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	15901000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	15913000	usd
CY2024Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	48000000	usd
CY2024Q1	ensg	Independent Operating Subsidiaries Under Medicare Probe Reviews IndependentOperatingSubsidiariesUnderMedicareProbeReviews	22	subsidiary
CY2024Q1	ensg	Centers For Medicare And Medicaid Services Compliance Audit Number Of Claims Reviewed For Each To Skilled Nursing Facility CentersForMedicareAndMedicaidServicesComplianceAuditNumberOfClaimsReviewedForEachToSkilledNursingFacility	5	claim
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001125376-24-000064-index-headers.html	Edgar Link	pending
0001125376-24-000064-index.html	Edgar Link	pending
0001125376-24-000064.txt	Edgar Link	pending
0001125376-24-000064-xbrl.zip	Edgar Link	pending
ensg-20240331.htm	Edgar Link	pending
ensg-20240331.xsd	Edgar Link	pending
ensg-20240331_g1.jpg	Edgar Link	pending
ensgq12024ex311.htm	Edgar Link	pending
ensgq12024ex312.htm	Edgar Link	pending
ensgq12024ex321.htm	Edgar Link	pending
ensgq12024ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
ensg-20240331_cal.xml	Edgar Link	unprocessable
ensg-20240331_def.xml	Edgar Link	unprocessable
ensg-20240331_lab.xml	Edgar Link	unprocessable
ensg-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ensg-20240331_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENSG
ENSIGN GROUP, INC Stock $ensg

2024 Q2 Form 10-Q Financial Statement

#000112537624000064 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG ENSIGN GROUP, INC Stock $ensg

2024 Q2 Form 10-Q Financial Statement

#000112537624000064 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG
ENSIGN GROUP, INC Stock $ensg